Form 4: Humana Director David T. Feinberg Reports Stock Unit Transactions

Humana director David T. Feinberg reported the acquisition of restricted stock units through deferred compensation and dividend reinvestment.

Summary

• David T. Feinberg, a director at Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
• The transactions include the acquisition of 783 restricted stock units as part of his annual director's fee, which are deferred until his resignation.
• Additionally, 131 restricted stock units were acquired through the conversion of director's cash fees, also deferred.
• A further 14 restricted stock units were acquired through the reinvestment of dividends on vested and deferred stock units.
• All stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon the director's resignation or as per the plan.

Sentiment

Score: 7

Explanation: The document reflects standard director compensation practices and does not indicate any significant positive or negative sentiment. It is a routine filing.

Positives

• The acquisition of stock units demonstrates the director's continued alignment with the company's long-term performance.
• The deferral of stock units until resignation suggests a long-term commitment to the company.
• The reinvestment of dividends into stock units further increases the director's stake in the company.

Future Outlook

The restricted stock units will be converted to Humana common stock on a 1-for-1 basis upon the director's resignation or as per the plan.

Industry Context

This filing is a routine disclosure of stock transactions by a company director, which is common practice in publicly traded companies.

Comparison to Industry Standards

• The use of restricted stock units as part of director compensation is a common practice among publicly traded companies.
• The deferral of these units until resignation is also a standard method to align director interests with long-term company performance.
• Many companies in the healthcare sector, such as UnitedHealth Group and CVS Health, also utilize similar compensation structures for their directors.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders by aligning director interests with long-term company performance.
• The transactions do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Humana, Director, Stock Units, Restricted Stock, Deferred Compensation, Dividend Reinvestment, Form 4, Beneficial Ownership